Vir Biotechnology, Inc. Common Stock (VIR) — Analysis Summary
Vir Biotechnology, Inc. Common Stock (VIR) has a market cap of $1.61B with year-over-year revenue growth of -7.6%. Net margin stands at -638.9%. The stock trades at a P/E ratio of -3.6.
Key Takeaways
- Revenue changed -7.6% year-over-year
- Net margin of -638.9%
- P/E ratio of -3.6
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, VIR posted revenue growth of -7.6% and trades at a P/E of -3.6.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.